Innovex Medical Files for IPO in Hong Kong to Boost Product Development
Innovex Medical Co., Ltd, a non-vascular interventional surgery solutions provider based in Shanghai, has filed...
Finance
ChainGen Bio Raises RMB 45M in Angel Round for X-oligo Conjugates Development
ChainGen Bio, a Shanghai-based developer of X-oligo conjugates (XOCs), has reportedly raised RMB 45 million...
Yibao Technology Secures Series A+ Funding to Expand Health Insurance Services
Yibao Technology Co., Ltd, a Shanghai-based service provider for city-level supplementary commercial insurance (“Huiminbao”) schemes,...
Mainline Biosciences Raises RMB 100M in Series A Financing for Peptide Drugs
Mainline Biosciences, a polypeptide drug developer based in Zhongshan, has reportedly raised close to RMB...
Jiangsu Trausim Raises RMB 100M in Series A Financing for Dental Implants
China-based Jiangsu Trausim Medical Instrument Co., Ltd, a wholly-owned subsidiary of Fulong Holdings and focused...
Xellsmart Raises RMB 200M in Series A1 Round for Stem-Cell Therapies
Xellsmart, a stem-cell startup based in Suzhou, has reportedly raised over RMB 200 million (USD...
SIMR Biotechnology Raises RMB 150M in Series C1 Financing Round
China’s Shanghai SIMR Biotechnology Co., Ltd has reportedly raised RMB 150 million (USD 20.7 million)...
Organon’s Q3 Results Show Women’s Health Segment Outperforms Amid Global Revenue Decline
US-based Organon & Co. (NYSE: OGN), a firm with a strong focus on women’s health...
Sophway Raises ‘Tens of Millions’ in Angel Round for Endoscope Development
Sophway Technology, a full HD endoscope system developer based in Shenzhen, has reportedly raised “tens...
Jumpcan Partners with Newsoara for PDE4 and Protease Inhibitors in China
China-based Jumpcan Pharmaceutical (SHA: 600566) has announced a partnership with compatriot firm Newsoara BioPharma Co.,...
Biomed Union Raises RMB 200M in Series B Round for Diagnostic Products
Biomed Union (formerly known as Shanghai Biomed-union Biotechnology Co., Ltd), a tumor molecular diagnostic technology...
Yaguo Technology Secures Series A+ Funding for Airway Management Devices
Yaguo Technology Co., Ltd, an airway management and respiratory therapy device maker based in Beijing,...
Pulnovo Medical Raises ‘Tens of Millions’ in New Financing Round
Pulnovo Medical, a pulmonary hypertension (PH) medical device maker based in Wuxi, has reportedly raised...
Fosun Pharma Terminates Equity Transfer Deal with OncoCare Medical
Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196, HKG: 2196) has announced the termination of...
Immunochina Pharmaceuticals Raises Funds for Gene Therapy Development
Beijing-based gene therapy specialist Immunochina Pharmaceuticals has reportedly raised “hundreds of millions” of renminbi in...
LEPU ScienTech Medical Technology Sets IPO Price Range Ahead of Hong Kong Listing
China-based LEPU ScienTech Medical Technology (Shanghai) Co., Ltd is gearing up for an initial public...
ImmVira Secures Series C+ Financing to Advance Oncolytic Virus and Exosome Programs
China-based biotech ImmVira has successfully secured its Series C+ financing, entering into agreements with a...
ArieMedi Secures Series A+ Financing to Expand Precision Navigation Solutions
ArieMedi Medical Science, a leading precision navigation solutions provider based in Beijing, has announced the...
ClinBrain Raises RMB 200 Million in Series C Financing to Boost Medical Big Data
Shanghai-based ClinBrain, a leading clinical data repository (CDR) and medical big data services provider, has...
Giant Biogene Set for IPO on Hong Kong Stock Exchange to Raise Funds for Expansion
China-based medical aesthetics company Giant Biogene Holding Co., Ltd (HKG: 2367) has announced plans to...